[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
December 8, 1989

As More Surgeons Opt for Autologous Transfusion Route, What's Ahead?

JAMA. 1989;262(22):3101-3102. doi:10.1001/jama.1989.03430220007001

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


NO TRANSFUSED BLOOD is as safe for a surgery patient as his or her own.

And given that it's sometimes impossible to operate with no transfused blood, an increasing number of surgeons are choosing to go the autologous route. A report at the annual meeting in Atlanta, Ga, of the American College of Surgeons drew one map of the possible terrain ahead.

Steven A. Gould, MD, associate professor of surgery at Michael Reese Hospital and Medical Center, Chicago, Ill, related its Department of Surgery's experience with the autologous blood program set up in December 1987. Gould credits the success of the comprehensive program in large part to the efforts of its special coordinator, Mary Stankos, RN. Other participants include Arthur L. Rosen, PhD; Lakshman R. Sehgal, PhD; Hansa L. Sehgal, MT; Phillip J. DeChristopher, MD; Armando R. Orlina, MD; and Gerald S. Moss, MD.

This Michael Reese program involved 161